Background: Germline testing for prostate cancer is on the increase, with clinical
implications for risk assessment, treatment, and management. Regardless of family history …

PURPOSE Guidelines for prostate cancer (PCA) germline testing (GT) have expanded, with
impact on clinical management and hereditary cancer assessment. African American (AA) …

PURPOSE: To identify the approximately 12% with inherited cancer predisposition, all men
with metastatic prostate cancer (mPC) should be offered germline genetic testing. This …

Germline genetic testing is revolutionizing prostate cancer (PCA) care, with studies
revealing inherited mutations (pathogenic variants) in a spectrum of cancer risk genes. 1-5 …

African-American men are more likely than any other racial group to die from prostate
cancer. The contribution of acquired genomic variation to this racial disparity is largely …

PURPOSE Germline testing (GT) is a central feature of prostate cancer (PCA) treatment,
management, and hereditary cancer assessment. Critical needs include optimized …

Background Germline genetic testing increasingly identifies advanced prostate cancer
(PCa) patients who are candidates for precision therapies. The Prostate Cancer Clinical …

Objective To review the current status of germline and somatic (tumour) genetic testing for
prostate cancer (PCa), and its relevance for clinical practice. Methods A narrative synthesis …

Methods A multidisciplinary steering committee guided the process of an environmental
scan to define the current landscape, as well as the perceived challenges, through …

Background Germline and tumour genetic testing in prostate cancer (PCa) is becoming
more broadly accepted, but testing indications and clinical consequences for carriers in …